RxDoctor Payments Data

Trelena Brown, PA

Physician Assistant · Clarkton, NCNPI 1881119873

Payments from drug & device makers

$231in general payments, 2019–2025

Across 16 payments — averaging $14.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$67
  • Boehringer Ingelheim$47
  • AstraZeneca$29
  • Takeda Pharmaceuticals U.S.A., Inc.$24
  • Ironwood Pharmaceuticals, Inc$17
  • Merck$12
  • plus $34 from 3 others

What the payments were for

  • Food & beverage$231100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$231 in reported general payments places this provider in the 45th percentile of 7,441 physician assistant providers in North Carolina.

See all physician assistant providers in North Carolina

Medicare billing

Part B allowed, 2024
$1,031
Medicare patients
16
Services billed
55

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide109$134,273
TrulicityDulaglutide46$64,893
JardianceEmpagliflozin63$60,080
EliquisApixaban81$54,845
FarxigaDapagliflozin Propanediol57$45,442
LinzessLinaclotide53$44,168
RybelsusSemaglutide17$29,364
Breo ElliptaFluticasone/Vilanterol23$15,633
Trelegy ElliptaFluticasone/Umeclidin/Vilanter13$14,702
JanuviaSitagliptin Phosphate16$11,133
TrintellixVortioxetine Hydrobromide16$8,294
Varenicline Tartrate20$7,139
SynjardyEmpagliflozin/Metformin Hcl11$6,764
Incruse ElliptaUmeclidinium Bromide18$6,389
Repatha SureclickEvolocumab11$5,873

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$67$163,637126 claims
Boehringer IngelheimJardiance, Synjardy$47$66,84474 claims
Lilly USA, LLCTrulicity$12$64,89346 claims
AstraZenecaFarxiga, Nexium$29$48,96070 claims
MerckJanuvia$12$11,13316 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$24$8,29416 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 7,441 physician assistant providers in North Carolina.

Other physician assistant in Clarkton

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →